BioAmber Closes Series B Funding Round

BioAmber (Minneapolis), a maker of biobased succinic and adipic acid, has completed a Series B funding round, raising $45 million. Naxos Capital Partners (Luxembourg), a venture capital firm, led the round, which was joined by Mitsui's venture capital arm. Mitsui & Co. announced a succinic acid supply agreement with BioAmber late last month. The round will fund construction of a major biosuccinic acid plant in North America and fund continued development work, including a license from DuPont on making 1,4-butanediol from succinic acid. The company's Series A...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers